Modulation of growth in retina-derived cells by extracellular matrices.
Intravitreal membranes from patients with proliferative vitreoretinopathy (PVR) consist partly of retinal glial (RG) and retinal pigment epithelial (RPE) cells surrounded by varying amounts of extracellular matrix (ECM). The contribution of the ECM to the growth of PVR membranes is unknown. This study was undertaken to determine if proliferation in cultured RPE and RG cells is affected by different substrates, including some ECM materials which have been identified in PVR membranes. Substrates tested included type I collagen, basement membrane Matrigel, and poly-D-lysine, as well as uncharacterized cell type-specific matrices deposited by cultured RPE and RG cells. Proliferation was quantified by 3H-thymidine incorporation and radioautography 24 hours after plating and by cell counts after 14 days in the presence of serum. Relative to uncoated culture plastic, growth of RPE cells was inhibited by Matrigel, enhanced by poly-D-lysine, and unaffected by type I collagen. In contrast, growth in RG cells was inhibited by type I collagen and unaffected by the other substrates. Analysis of the timing of DNA synthesis after plating suggested that the substrates which affected RPE growth did so by altering the fraction of cycling cells rather than the cell cycle time. For the cell-derived matrices, heterotypic matrix (matrix produced by the other retinal cell type) enhanced the growth of both RPE and RG. The results suggest that the ECM may modify the growth of cells contributing to PVR membranes. Of note is that the cell-derived matrices reciprocally stimulated growth of RG and RPE cells, cell types which may interact in PVR membranes.
Department of Ophthalmology, Medical College of Wisconsin, Milwaukee 53226.
D F
DF
Williams
J M
JM
Burke
D000818:Animals; D001345:Autoradiography; D002417:Cattle; D002452:Cell Count; D002455:Cell Division / Q000502:physiology; D002478:Cells, Cultured; D003094:Collagen / Q000502:physiology; D003470:Culture Media; D004338:Drug Combinations; D016326:Extracellular Matrix Proteins / Q000502:physiology*; D007797:Laminin / Q000502:physiology; D008858:Microscopy, Phase-Contrast; D010857:Pigment Epithelium of Eye / Q000166:cytology; D011107:Polylysine / Q000502:physiology; D011509:Proteoglycans / Q000502:physiology; D011817:Rabbits; D012160:Retina / Q000166:cytology*; D012165:Retinal Ganglion Cells / Q000166:cytology
D003470:Culture Media; D004338:Drug Combinations; D016326:Extracellular Matrix Proteins; D007797:Laminin; D011509:Proteoglycans; C059485:matrigel; D011107:Polylysine; D003094:Collagen